PMC Links for Books (Select 4855228) - PMC

Select item 70651211.

Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients

S. Gerdes, A. Pinter, C. Papavassilis, M. Reinhardt

J Eur Acad Dermatol Venereol. 2020 Mar; 34(3): 533–541. Published online 2019 Oct 10. doi: 10.1111/jdv.16004

PMCID:: PMC7065121

Select item 69579202.

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5‐year Results from the Phase 3 FUTURE 1 Study

Philip J. Mease, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, Juergen Rech, Stephen Hall, Piet Geusens, Pascale Pellet, Eumorphia Maria Delicha, Luminita Pricop, Shephard Mpofu, on behalf of the FUTURE 1 study group

ACR Open Rheumatol. 2020 Jan; 2(1): 18–25. Published online 2019 Nov 14. doi: 10.1002/acr2.11097

PMCID:: PMC6957920

Abstract Article PDF–427K

Select item 67440733.

Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study

Xenofon Baraliakos, Juergen Braun, Atul Deodhar, Denis Poddubnyy, Alan Kivitz, Hasan Tahir, Filip Van den Bosch, Evie-Maria Delicha, Zsolt Talloczy, Anke Fierlinger

RMD Open. 2019; 5(2): e001005. Published online 2019 Sep 3. doi: 10.1136/rmdopen-2019-001005

PMCID:: PMC6744073

Abstract Article PDF–338K

Select item 63366334.

Adverse drug events observed with 150 mg versus 300 mg secukinumab for the treatment of moderate to severe plaque psoriasis: A systematic review and meta-analysis

Li Zhang, Hua Yang, Qihong Chen, Jing Zhao

Medicine (Baltimore) 2019 Jan; 98(2): e14042. Published online 2019 Jan 11. doi: 10.1097/MD.0000000000014042

PMCID:: PMC6336633

Abstract Article PDF–1.3M

Select item 57418725.

Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3

Karel Pavelka, Alan Kivitz, Eva Dokoupilova, Ricardo Blanco, Marco Maradiaga, Hasan Tahir, Luminita Pricop, Mats Andersson, Aimee Readie, Brian Porter

Arthritis Res Ther. 2017; 19: 285. Published online 2017 Dec 22. doi: 10.1186/s13075-017-1490-y

PMCID:: PMC5741872

Abstract Article PDF–865K

Select item 40652776.

Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy

Paolo Gisondi, Camilla Dalle Vedove, Giampiero Girolomoni

Dermatol Ther (Heidelb) 2014 Jun; 4(1): 1–9. Published online 2014 Jan 23. doi: 10.1007/s13555-014-0042-5

PMCID:: PMC4065277

Abstract Article PDF–556K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 6

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity